// App-Quantinova.ai

1317 : Citrullinated glucose-regulated protein 78 is a novel candidate target for cancer immunotherapy

Researchers

Presenter

  • Victoria Brentville

Principal Investigators

  • Jia Chua

  • Peter Symonds

  • Anne Skinner

  • Ian Daniels

  • Katherine Cook

  • Lindy Durrant

Medical Centers

  • Scancell, Nottingham, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Peripheral blood mononuclear cell

  • Interferon-gamma

Drug/Treatment

  • Interferon Gamma

  • MPLA

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved